The therapeutic effect of Rosuvastatin on cardiac remodelling from hypertrophy to fibrosis during the end-stage hypertension in rats Article

Zhang, WB, Du, QJ, Li, H et al. (2012). The therapeutic effect of Rosuvastatin on cardiac remodelling from hypertrophy to fibrosis during the end-stage hypertension in rats . Journal of Cellular and Molecular Medicine, 16(9), 2227-2237. 10.1111/j.1582-4934.2012.01536.x

Open Access

cited authors

  • Zhang, WB; Du, QJ; Li, H; Sun, AJ; Qiu, ZH; Wu, CN; Zhao, G; Gong, H; Hu, K; Zou, YZ; Ge, JB

sustainable development goals

authors

publication date

  • September 1, 2012

published in

keywords

  • 3-hydroxy-3-methylglutaryl-coenzyme-A (HMG-CoA)-reductase inhibitors
  • APOPTOSIS
  • Cell Biology
  • DYSFUNCTION
  • EXPRESSION
  • HEART-FAILURE
  • ISCHEMIA
  • Life Sciences & Biomedicine
  • MECHANISMS
  • MICRORNAS
  • Medicine, Research & Experimental
  • PRESSURE
  • Research & Experimental Medicine
  • Rosuvastatin
  • STATIN THERAPY
  • SURVIVAL
  • Science & Technology
  • apoptosis
  • cardiac remodelling
  • fibrosis
  • hypertrophy
  • old-aged spontaneously hypertensive rats

Digital Object Identifier (DOI)

publisher

  • WILEY

start page

  • 2227

end page

  • 2237

volume

  • 16

issue

  • 9